We analyzed the weighted 2001-2002 National Health and Nutrition Examination Survey data to assess potential differences in mean total 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) TEQ between various groups of individuals and to determine serum reference concentrations for polychlorinated dibenzo-p-dioxins, dibenzofurans (PCDD/Fs) and dioxin-like polychlorinated biphenyls (PCBs) in the general US population. Differences appeared to exist between female smokers and non-smokers and between non-Hispanic groups and all other races. Potential differences were also observed among the four age groups with an increasing trend in mean total TCDD TEQ with increasing age. Both age and gender appeared to confound the association between smoking status and total TCDD TEQ, dictating the need for further analysis. As anticipated, PCBs contributed appreciably to the total TCDD TEQ levels in the referent population and accounted for 38% to 41% of the total TEQ depending on age. Nearly 80% of the mean total TCDD TEQ was attributable to four PCDD/F congeners and three PCB congeners. In this analysis, two methods were used to assess samples where the concentrations were below the limits of detection (LODs), and this did not have significant impact on the mean total TCDD TEQ at the higher percentiles and for older individuals.
Introduction
Polychlorinated dibenzo-p-dioxins (PCDDs), polychlorinated dibenzofurans (PCDFs), and polychlorinated biphenyls (PCBs) are classes of structurally similar halogenated aromatic hydrocarbons. There are 210 PCDD/F and 209 PCB congeners, of which only seventeen 2,3,7,8-substituted PCDD/Fs and 12 PCBs elicit a similar spectrum of effects through a common mechanism of action. Of the PCDD/F congeners, 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) and 1,2,3,7,8-pentachlorodibenzo-p-dioxin have been studied in the greatest detail with TCDD considered the most potent congener of the 29 PCDD/Fs and PCBs possessing dioxinlike properties. Over the past 30 years, public concerns regarding the toxic effects of PCDD/Fs and PCBs have been based in part on the ubiquitous and persistent nature of these compounds, as well as their ability to bioaccumulate in the food chain (USEPA, 2003) . Research studies on PCDD/Fs and PCBs conducted in the past three decades have primarily characterized the major sources of these compounds, their toxicological effects in animals, and portions of the molecular mechanism of action responsible for their toxicity (Kociba et al., 1978; Birnbaum, 1994; Safe and Krishnan, 1995; Safe, 2001; USEPA, 2003) . However, there is currently neither scientific consensus regarding the health risks posed to humans exposed to environmental levels of these chemicals nor have the toxicological properties of each congener been characterized in sufficient detail to support the development of toxicity criteria on a congener by congener basis. Such difficulties have compelled scientists and regulatory agencies to rely on the toxic equivalency factor (TEF) approach to evaluate potential health effects of PCDD/F and PCB congeners in humans (van den Berg et al., 1998; Haws et al., 2006) when conducting risk assessments.
Originally developed to assess toxicity and facilitate the conduct of environmental risk assessments involving mixtures of PCDD/Fs and PCBs, the TEF paradigm assigns a potency value to each 2,3,7,8-substituted PCDD/F congener, as well as to the 12 dioxin-like PCB congeners, based on the available toxicology data (van den Berg et al., 1998; Haws et al., 2006) . In the past few years, use of this approach has expanded tremendously and is now frequently used to determine whether people and/or property contain levels above referent levels. However, accurate comparisons of exposed individuals or groups to controls or referent concentrations can be difficult to complete since many studies that have assessed referent concentrations of PCDD/Fs and PCBs in the general population often provide insufficient data.
In the previous two decades, only a few studies have described referent concentrations of PCDDs, PCDFs and PCBs in human populations, and these studies are somewhat limited because they were based on relatively small populations or composite sample results (Graham et al., 1986; Kang et al., 1991; Schecter et al., 1991 Schecter et al., , 1996 . Moreover, serum concentrations reported in many of these studies are not likely to be representative of current concentrations due to the steady decline in dioxin levels over the past 20 years (Aylward and Hays, 2002; Lorber, 2002) . Consequently, for evaluating blood PCDD/F and PCB biomonitoring results from potentially exposed populations, it is important to compare the results to concentrations from referent populations that were collected in a similar time period.
In 2004, Patterson et al., analyzed PCDD/F and PCB concentrations in serum collected between 1996 and 2001 from 588 individuals in North Carolina, New York, Louisiana and Missouri and reported the total TCDD TEQ. While this study was valuable in establishing agespecific background PCDD/F concentrations in human serum, several limitations hinder the application of the results for comparative purposes. For example, although the authors calculated summary statistics for TCDD and the total TCDD TEQ for four separate age groups using the seventeen 2,3,7,8-substituted PCDD/Fs and four coplanar PCBs, they did not stratify their results by any other demographic characteristics including gender or smoking status. Moreover, it appears that there may have been individuals included in the analysis that did not have complete congener profiles. The inclusion of individuals with missing data could potentially skew the study results and impact conclusions drawn from these data. This study was also limited since it only included individuals from four states and, therefore, may not be useful for comparisons to individuals from other geographic areas. Finally, because the authors did not report or provide access to the raw data, it is not possible to conduct further analyses of their data set, such as assessing PCDD/F-referent levels separately from PCB levels and evaluating congener patterns and detection limits.
Another current source of data for referent levels of PCDD/ Fs and PCBs is the CDC's National Center for Health Statistics (NCHS), which conducts a survey every two years to collect health and nutritional information on the US population. The National Health and Nutrition Examination Survey (NHANES) conducted during 1999-2000 supplied data on 116 chemicals analyzed in the blood of selected survey participants and was the first NHANES survey to include PCDD/F and PCB serum analyses (NCHS, 2003) . Although this survey provided the first opportunity to assess referent levels of certain environmental chemicals in the US population, the data collected had a number of deficiencies including high detection limits and a lack of analytical results for two of the 2,3,7,8-substituted PCDD/Fs. The possibility that exclusion of these two congeners would significantly affect the total TEQ of the general US population is minimal; however, both 1, 2, 3, 4, 7, 2, 3, 4, 7, 8, 9 -HpCDF may be detected at high concentrations in certain occupationally exposed individuals, thereby necessitating their inclusion in TEQ and risk calculations.
Recently, the CDC made a new data set available for selected 2001-2002 NHANES participants. Sample collection methodologies for this survey appear to have been adjusted in an effort to address concerns regarding specimen analysis and relevance of results. In particular, the volume of specimen analyzed for each participant was increased, thus improving the detection limits. Moreover, analyses were conducted for all seventeen 2,3,7,8-substituted PCDD and PCDF congeners and nine of the dioxin-like PCBs, and the raw data are available for further analysis.
As the need to evaluate populations exposed to PCDDs, PCDFs and PCBs due to accidental industrial releases or contact with historically contaminated environmental media continues to increase, the determination of referent concentrations of these chemicals in the human population is becoming increasingly important. Hence, the objectives of this paper are (1) to provide scientists, regulatory agencies, the regulated community, and the general public with descriptive reference statistics for PCDD, PCDF and PCB levels in the US population using the 2001-2002 NHANES data and (2) to compare our summary statistics for the most recent NHANES data to other PCDD/F-and PCBbiomonitoring results.
Methods

Data Collection and Analytical Techniques
The CDC measured PCDD/Fs and PCBs in blood serum collected from a subset of NHANES participants that were surveyed between 2001 (NCHS, 2005a . Complete details regarding the procedures, survey components, questionnaires, and examination are available at the CDC NCHS website: http://www.cdc.gov/nchs/nhanes.htm.
Information specific to the current (1999-2002) NHANES survey, including operations manuals and consent documentation, is available at http://www.cdc.gov/nchs/about/major/ nhanes/nhanes99-02.htm.
All 2,3,7,8-substituted PCDD/Fs, as well as PCBs 81, 105, 118, 126, 156, 157, 167, 169 and 189 were quantified in this study. Analytes were measured using high-resolution gas chromatography and/or isotope-dilution high-resolution mass spectrometry (HRGS/ID-HRMS) as described in the Third Report (NCHS, 2005b) . Since the method for assessing non-detect concentrations (C ND ) of PCDD/Fs and dioxin-like PCBs in human serum can influence the mean total TCDD TEQ calculated, analytical results with non-detect concentrations were managed using two different approaches. For the first approach, samples with concentrations below the limit of detection (LOD) were assumed to have a concentration equal to zero (C ND ¼ 0). For the second approach, samples with concentrations below the LOD were assumed to have a concentration equivalent to the proxy value assigned by the CDC, which is equal to the LOD divided by the square root of two (C ND ¼ LOD= ffiffi ffi 2 p ). Although both of these approaches were used to calculate total TCDD TEQ levels, the values determined using C ND ¼ 0 were meant to help assess the effect LODs had on the data and are not meant to be used as reference values with which to compare individuals or groups of individuals. The total TCDD TEQ values calculated using C ND ¼ 0 are, therefore, not presented in any of the tables.
Statistical Analyses
Lipid-adjusted PCDD, PCDF and PCB serum concentration data (PCDD/F in pg/g, PCB in ng/g) released in May 2005 as part of the NHANES 2001-2002 survey results were obtained from the CDC website. The data files were converted from a SAS format to Microsoft Excel format using the SYSTAT 11.0 statistical software package. Serum concentration data were linked to gender, race, smoking status, and age demographics using the unique survey participant identifier assigned to each subject. Only data from participants with complete PCDD/F and PCB profiles were selected for analysis. PCDD/F and PCB TEQs for individual subjects were calculated by summing the product of each congener's concentration and the associated 1998 World Health Organization TEF (van den Berg et al., 1998) .
The mean, geometric mean, and 25th, 50th, 75th and 95th percentile TEQ concentrations were characterized by gender, race, smoking status and age for the unweighted data set using Microsoft Excel. To eliminate any bias inherent in the NHANES 2001-2002 study design, weighted summary statistics were also calculated using the dioxin subset-specific 2-year weights included in the NHANES dioxin data file (NCHS, 2005a) . These weighted statistics were calculated using SYSTAT and then summarized using Microsoft Excel. Ninety-five percent (95%) confidence intervals for the weighted mean TEQ levels were calculated using Sudaan 9.0.1. This program estimated the upper and lower 95% confidence limits using the Taylor series method as outlined in the NHANES 1999-2002 analytic guidelines (CDC, 2002 (CDC, , 2004 . While it is possible to use a t-test to explicitly test whether the mean TEQ values of various groups are statistically different, we have chosen to compare groups based upon the confidence intervals of the mean. Although this approach is not a true hypothesis test of population differences in mean values, it does provide a useful approximation of those groups most likely to be characterized as having different mean values across groups.
The average percent contribution of each congener to the total TEQ was calculated by averaging the percent contribution of that congener to the total TEQ across all subjects. LOD values were calculated from C ND using the equations previously described in Data Collection and Analytical Techniques.
Results
For comparative purposes, total TCDD TEQs were calculated for four different data subsets. The first two, TEQ PCDD/F and TEQ PCB , were determined using only the contributions from the 17 PCDD/F or nine PCB congeners the CDC measured, respectively. The third, TEQ 17-9 , was calculated using contributions from all 17 PCDD/F congeners plus all nine PCB congeners, while the fourth, TEQ 17-3 , used contributions from all 17 PCDD/F congeners plus the three coplanar PCB congeners (PCB 81, PCB 126 and PCB 169) . Only individuals with a complete data set, that is no congener data was missing, were included in this analysis giving an n of 1081 for the TEQ PCDD/F , TEQ PCB and TEQ 17-9 subsets and an n of 1091 for the TEQ 17-3 subset.
Tables 1a-d present the various summary statistics for the four data subsets by gender, age, race and smoking status assuming C ND ¼ LOD= ffiffi ffi 2 p . Mean lipid-adjusted total TEQs appear to be different for smokers and non-smokers in all of the sample sets. Additionally, differences seem to exist between most of the age groups in the four subsets with no differences observed only between the 20-29 and 30-44 age groups in the TEQ 17-3 subset. Overall, the oldest group of individuals had average levels more than two times that of the youngest group. More importantly, analysis of all the sample sets demonstrated an increasing trend in mean total TEQ with increasing age, as have other studies (Kang et al., 1997; Falk et al., 1999; Bates et al., 2004; Patterson et al., 2004) . Evaluation of PCDD/F and dioxin-like PCB serum concentration Ferriby et al.
adipose tissue, and the increasing variability in total TEQ with age. Also striking were the potential differences between races. While the mean total TEQ for non-Hispanic Whites did not seem to differ from non-Hispanic Blacks, both of these groups had TEQ levels higher than those for Mexican Americans, other Hispanics (all four subsets) and individuals in the ''Other Race'' category (TEQ PCDD/F and TEQ 17-9 subsets). Indeed, Needham et al. (2005) concluded that, relative to their distributions in the US population, Mexican Americans were the least likely racial/ethnic group to have TEQ concentrations above the 95th percentile; however, it should be noted that the authors calculated their TEQ statistics using different methods and a different subset of congeners than what is presented here.
In an effort to assess the effects that gender, age and smoking status have on one another with respect to total TEQ, we compiled pair cross tables for each of the four data subsets again assuming C ND ¼ LOD= ffiffi ffi 2 p (Table 2a-d) . Interestingly, smokers did not appear to vary from nonsmokers across most age categories for all subsets; however, 60 þ years smokers did seem to differ considerably from 60 þ years non-smokers for the TEQ 17-9 (Figure 2 ), TEQ PCB and TEQ 17-3 subsets. Even more surprising, the mean total TEQ for non-smokers 60 years and older was an average 39% higher than that for smokers in the same age group, although this effect is likely due to the fact that the mean age of non-smokers 60 years and older was 71.6 years (67.9-75.3) while the mean age of smokers X60 years was 66.2 years (61.4-71.0).
In addition to age, gender also appeared to affect the association between smoking status and total TEQ. Although initial results indicated the existence of possible differences between smokers and non-smokers for all four sample sets, further stratification by gender demonstrated potential confounding since there appears to be a difference between female smokers and non-smokers, with female smokers having a much lower TEQ, but no such difference seems to exist between male smokers and non-smokers. While unusual, significantly lower serum dioxin levels in women have been previously associated with smoking and may be due to increased dioxin metabolism augmented by tobacco smoke in this gender (Fierens et al., 2005) .
As anticipated, the mean total TEQ reported for each sample set increased as the number of congeners in each set increased with TEQ 17-9 4TEQ 17-3 4TEQ PCDD/F 4TEQ PCB (Table 1a-d and 2a-d) . On average, the mean total TEQ for the 17 PCDD/Fs plus nine PCBs was 64% higher than the mean total TEQ for the 17 PCDD/Fs alone, while the mean total TEQ for the 17 PCDD/Fs plus the three coplanar PCBs was 21% higher, indicating that PCBs contribute considerably to the total TEQ levels in the background population.
To determine which PCDD/Fs and PCBs contributed the most to the total TEQ, as well as the relative percentages of the four main classes of chemicals used to calculate total TEQ, we evaluated the relative contribution of each of the PCDD/F and PCB congeners to the total TEQ. Dioxins and mono-ortho PCBs contributed the most to total TEQ with respective contributions of 43.1% and 27.7%. Furans contributed 17.6% to the total TEQ, and coplanar PCBs accounted for 11.5%. Of the 17 PCDD/Fs, 2,3,7,8-TCDD, 1,2,3,7,8-PeCDD, 1,2,3,6,7,8-HxCDD and 2,3,4,7,8-PeCDF collectively accounted for 48% and 66% of the total TEQ for subsets TEQ (Figure 3 ) and TEQ 17-3 , respectively, while 31% of the total TEQ 17-9 was attributable to PCBs 126, 156 and 157 (Figure 3) . Fifteen percent of the total TEQ 17-3 was attributable to PCB 126 alone. These findings are consistent with Patterson et al. (1994) and Kang et al. (1997) who demonstrated that many coplanar PCBs have lesser potency, but their concentrations are often much higher than concentrations of TCDD, to the extent that their relative contribution to the total TEQ is potentially substantial and should not be discounted. Furthermore, as shown in Table 3 , the congener profile of the US population varies slightly from age group to age group. While the patterns are not overwhelmingly different, notable increases in the contribution of 1,2,3,7,8-PeCDD and 1,2,3,6,7,8-HxCDD and decreases in the contribution of TCDD and PCB 157 to the total TEQ can be observed. These subtle differences could be due to changes in exposure patterns, differences in elimination rates, or simply a result of detection limits.
As previously described, two different methods were employed to evaluate non-detect analytical results (C ND ¼ 0 vs. C ND ¼ LOD= ffiffi ffi 2 p ) in an effort to assess the impact of LODs on each congener's percent contribution to the total Age (years) Figure 2 . Mean TEQ 17-9 and 95% confidence intervals by smoking status and age. Smokers did not seem to vary from non-smokers across most age categories; however, 60 þ smokers did appear to differ moderately from 60 þ non-smokers. The mean total TEQ for non-smokers 60 years and older was an average 39% higher than that for smokers in the same age group; however, this may be a result of differences in survival rates between smokers and non-smokers 60 years and older. 2, 3, 7, 1, 2, 3, 7, 1, 2, 3, 6, 7, 3, 4, 7, 8 -PeCDF collectively accounted for 48% of the total TEQ 17-9 , while 31% of the total TEQ 17-9 was attributable to PCBs 126, 156 and 157 assuming C ND ¼ LOD= ffiffi ffi 2 p . TEQ ( Figure 3) . The congeners affected the most included 2, 3, 7, 1, 2, 3, 7, 1, 2, 3, 6, 7, PCB 126 and PCB 157 . A comparison of Figure 3 with Figure 4 , however, shows that both 1,2,3,6,7,8-HxCDD and PCB 126 have a high fraction of samples with concentrations greater than the LOD, thereby minimizing the effects the detection limits of these congeners have on the total TEQ since congeners with fractions nearer to unity are considered to be measured to a greater degree of certainty. In contrast, 2,3,7,8-TCDD, 1,2,3,7,8-PeCDD and PCB 157 have low fractions of samples with concentrations greater than the LOD and, therefore, the individual TEQ values for these congeners may be overestimating the true levels found in the referent population. Indeed, while PCB 157 contributes more to the total TEQ than PCB 118 when C ND ¼ LOD= ffiffi ffi 2 p , the opposite is true when C ND ¼ 0, clearly demonstrating the effect LODs can have on total TEQ calculations. It should nevertheless be noted that, although the mean total TEQ may be somewhat overestimated due to the significant contribution of these three congeners, any overestimation of our results does not affect comparisons between groups considering that these congeners were infrequently detected for all individuals in each of the various categories analyzed. Figure 5 demonstrates the effects of C ND on the overall values of the mean TEQ PCDD/F , TEQ PCB , TEQ 17-9 and TEQ . In all cases, as expected, the cumulative TEQ distributions were reduced when C ND ¼ 0 was used instead of C ND ¼ LOD= ffiffi ffi 2 p . This effect was much less pronounced at higher percentiles, however, as a larger fraction of samples at these percentiles tended to contain measurable PCDD/F and PCB concentrations. Indeed, the TEQ for each of the four groups decreased approximately 70% at the lower percentiles but only 5% at the higher percentiles, suggesting that the method of evaluating non-detect concentrations is less important at higher percentiles. Considering the 95th percentile or maximum background values are typically used to assess exposure to PCDD/Fs and PCBs, the impact of LODs on these values should be minor with regard to the risk assessment process. Since age is such a strong predictor of total TEQ, we analyzed the effect C ND had on the total TEQ while considering age as well. As shown in Figure 6 , the mean difference in TEQ decreases by about 8 p.p.t. ) and slightly more than 3 p.p.t. (TEQ PCDD/F ) from the youngest individuals to the oldest suggesting that, for older individuals, the detection limits are not as important since these persons likely have quantifiable serum levels of dioxins, furans and PCBs.
Further analyses to determine the effects of LODs on total TEQ with respect to age, race, gender and smoking status revealed that, for all four variables, the total TEQ 17-9 calculated when using C ND ¼ LOD= ffiffi ffi 2 p was higher than when C ND ¼ 0 was used (Figure 7) . In fact, the total TEQ 17-9 for the 45-59 and 60 þ age groups and the ''nonHispanic Black'' and ''Other Race'' groups were the only values that did not seem to be affected by using
The results for age were expected, however, since younger people were likely exposed to lesser concentrations of PCDD/Fs and PCBs than were older individuals.
Discussion
Our initial analyses of the NHANES PCDD/F and PCB serum concentration data identified potential differences in mean total TEQ between non-Hispanics (Whites and Blacks) and all other races, female smokers and non-smokers, and among the various age groups. However, while the reference TEQs we have calculated are accurate for comparisons with potentially exposed individuals or populations, it is important to note that the possible differences we have discovered between and among different groups are the results of preliminary analyses. Currently, it is unknown whether differences between groups of individuals exist due to disparities in survival or differences associated with the Evaluation of PCDD/F and dioxin-like PCB serum concentration Ferriby et al.
variables being measured. Indeed, both gender and age appear to confound the association between smoking status and mean total TEQ, dictating the need for further analyses. By developing a multivariable regression model that is predictive of mean total TEQ and considers the confounding and biological effects of the different variables, concerns regarding differences between and among groups can be easily addressed.
In the interim, our results can provide relevant, up-to-date statistics, specifically the mean total TEQ and numerous percentiles, that can be used as reference values to evaluate data concerning PCDD/F and PCB levels in exposed or potentially exposed individuals. In an effort to accurately characterize typical background levels of dioxin-like compounds on a TEQ basis, we analyzed data only from participants with complete PCDD/F and PCB profiles and computed percent contributions using all of these individuals. While excluding individuals without complete profiles has the potential to bias the results, comparison of our results with those of Patterson et al. (2005) (data not shown) demonstrates that the overall conclusions reached here are reasonably consistent with the Patterson group which included subjects with and without complete profiles. Furthermore, we chose not to use the ''top 5%'' approach that Needham et al. (2005) used to compute percent contributions for two reasons. First, the percent contribution of high contributing congeners increases with increasing total TEQ, and secondly, this trend correlates with the age relationship (data not shown). Owing to these factors it is unlikely that the top 5%, which accounts only for the oldest individuals in the data set, would have an average congener distribution that is characteristic of the general US population.
In general, the applicability of our analyses can be illustrated by comparing what we have determined to be characteristic levels of these compounds to the results of a recent pilot exposure investigation (PEI) conducted by the Michigan Department of Community Health (MDCH) and the Agency for Toxic Substances and Disease Registry. Specifically, the referent concentrations we have calculated can be used to evaluate biological monitoring data collected to assess dioxin exposure of adults living in the Tittabawassee River Flood Plain (Saginaw County, MI, USA).
Since the PEI study data were analyzed for the 17 PCDD/Fs and four coplanar PCBs and included only serum samples from individuals 45-59 and 60 þ years, we chose to evaluate this data using the TEQ 17-3 reference values we calculated for these age groups. Figure 8 compares the mean TEQ 17-3 for age groups 45-59 and 60 þ years from the NHANES data and the mean TEQ for the same age groups from the MDCH data. Interestingly, there is not an age related increase in total dioxin TEQ for the MDCH participants. While this is inconsistent with our results, as well as the findings of Kang et al. (1997 ), Falk et al. (1999 , Bates et al. (2004) and Patterson et al. (2004) , it may be due to the large variability in the PEI data. Additionally, the 95% confidence intervals for the MDCH mean TEQs overlap the 95% confidence intervals for the NHANES mean TEQs, suggesting that the MDCH mean total dioxin TEQ is not likely to be different from the NHANES mean total dioxin TEQ for both age groups. Just as notable, the NHANES data set did not include PCB 77, whereas the MDCH analysis included all four coplanar PCBs (77, 81, 126 and 69) resulting in slightly higher values than the referent population. It is likely that the values estimated based on our analysis for the TEQ 17-3 subset would be even more consistent with the MDCH values had we been able to include PCB 77, indicating that the ''exposed'' group of individuals evaluated by the MDCH are not likely to have TCDD TEQ serum concentrations different than the general US population. Overall, the comparison of the MDCH data with our results provides a valuable tool for assessing PCDD/F and PCB serum concentrations of study populations and helps to determine if further studies are needed and the direction of those studies. Until now, results from the MDCH exposure study would have been evaluated against the data reported in Patterson et al. (2004) . However, while the study by Patterson et al. (2004) represents an important contribution to the literature, several aspects of this study limit its usefulness. There are several advantages of using the summary statistics developed here based on the most recent NHANES data set to interpret levels measured in people. First, the NHANES data used in our analysis is likely to be more representative of current background exposures because it was collected more recently (2001 ( -2002 ( compared to 1996 ( -2000 and also because it was collected on a national scale. As shown in Figure 9 , the mean TCDD TEQ concentration reported by Patterson et al. (2004) for the four age groups is, unexpectedly, 2.3-7.3 p.p.t. lower than that calculated based on the most recent NHANES data. Figure 10 illustrates that the range of PCDD/F TEQ levels for the 57 civilian and nonVietnam veterans 26-45 years of age that participated in National Human Adipose Tissue Survey (NHATS) in 1980 -1981 (USEPA, 1990 ) is much larger and slightly broader than that for the 408 individuals 26-45 years of age that 
The cumulative TEQ distributions were reduced when C ND ¼ 0 was used instead of C ND ¼ LOD= ffiffi ffi 2 p . This effect was much less pronounced at higher percentiles, as a larger fraction of samples at these percentiles tended to contain measurable PCDD/F and PCB concentrations. The TEQs for all four groups decreased approximately 70% at the lower percentiles but only 5% at the higher percentiles. Figure 6 . Mean difference of TEQ 17-9 using C ND ¼ 0 and C ND ¼ LOD= ffiffi ffi 2 p vs. age. The mean difference (unweighted data) was calculated by subtracting the total TEQ using C ND ¼ 0 from the total TEQ using C ND ¼ LOD= ffiffi ffi 2 p . Overall, the mean difference decreases by about 8 p.p.t. ) and more than 3 p.p.t. (TEQ PCDD/F ) from the youngest individuals to the oldest suggesting that, for younger individuals, a greater proportion of the total TEQ is due to non-detected analytical results. Both plots have a logarithmic trend. Approximately 83% and 67% of the variability in the mean difference in TEQ 17-9 and TEQ PCDD/F , respectively, can be explained by age. . Mean TEQ 17-9 and 95% CI by age, race, gender, and smoking status for C ND ¼ 0 and C ND ¼ LOD= ffiffi ffi 2 p . The total TEQ 17-9 calculated when using C ND ¼ LOD= ffiffi ffi 2 p was higher than when C ND ¼ 0 was used for all four variables. The total TEQ 17-9 for the 45-59 and 60 þ years age groups and the ''NHB'' and ''Other Race'' groups were the only values not affected by using While unusual, the reversed difference noted between our results and the results of Patterson et al. (2004) is likely attributable to several factors including (1) the collection of data on a broader scale, (2) a higher number of participants, (3) the method for handling participants with incomplete data sets and/or, (4) the approach for handling non-detected analytical results. These last two factors are particularly likely to have substantially impacted the results of Patterson and colleagues (2004) since the authors used C ND ¼ LOD/2 to handle non-detects and individuals with incomplete congener data sets were included in their analysis with measurements for analytes that could not be reported because of QA/QC procedures assigned a value of zero. Furthermore, while it is unclear what effects LODs had on the Patterson et al. (2004) results, we assessed the effect detection limits had on the mean total TEQ for the subsets TEQ 17-9 and TEQ 17-3 , which was helpful in determining which congeners had LODs that could have impacted the mean total TEQ.
Other advantages of the NHANES 2001-2002 data include presentation of congener profiles, availability of the raw data, and the larger number of PCBs included in the analysis. This last point is of particular importance since there are 12 PCBs with dioxin-like activity and only four of these PCBs were included in the Patterson et al. (2004) data set. Although our analysis only included nine PCBs, the mean total TEQ calculated using the 17 PCDD/Fs plus nine PCBs is likely to be more accurate and representative of the background total TCDD TEQ than that calculated using the data from Patterson et al. (2004) .
Overall, the results of our analysis will be useful when evaluating the PCDD/F and PCB serum concentrations of individuals or populations potentially exposed to these chemicals. As our case study demonstrates, the data exhibited in Tables 1a-d Figure 8 . Comparison of mean TEQ 17-3 and 95% CI by age category for the NHANES and MDCH PEI* data. The overlapping confidence intervals suggest that the MDCH mean total dioxin TEQ is not different from the NHANES mean total dioxin TEQ for both age groups. The PEI data was compared to the NHANES TEQ 17-3 because the PEI study only measured the 17 PCDD/Fs and the four coplanar PCBs. PEI data was only available for individuals 45-59 and 60 þ years of age. *Individual PEI data were not available to determine the age distributions of individuals within each age group. confidence intervals can be used to evaluate populations, individual blood serum levels can be compared to the mean and the entire distribution. It is important to note, however, that while these data are intended to meaningfully enhance the biomonitoring process for PCDD/Fs and PCBs, no conclusions regarding the potential health status of a group or individual can be drawn from these data.
